Effects of Chronic Neuroleptic Therapy on Human PRL Secretion and Testicular Function

References

• Bartke A L. Effects of prolactin and luteinizing hormone on the cholesterol stores in the mouse testis. J Endocrinol 1971; 49: 311–316
   PubMed Web of Science ®Google Scholar
• Beaumont J V. The effect of phenothiazine on endocrine function. II. Br J Psychiatry 1974; 124: 420–430
   Google Scholar
• Bernini G, Franchi F, Pucci E, Gasped M, Sgrilli R, Magrini G, Luisi M. Effetti della iperprolattinemia indotta con sulpiride sulla secrezione di testosterone dopo HCG e sulla attivita aromatizzante e 5α reduttasica in soggetti adulti normali. Acts of the “Giornate Endo-crinologiche Pisane”. Pisa 1979, in press
   Google Scholar
• Besser G M, Thorner M. Prolactin and gonadal function. Path Biol 1975; 23: 779–782
   PubMedGoogle Scholar
• Beumont P, Bruwer J, Pimstone B, Vinik A, Utian W. Brom-ergocryptine in the treatment of phenothiazine-induced galactorrhea. Br J Psychiat 1975; 126: 285–288
   Google Scholar
• Beumont P JV, Corker C S, Friesen H G, Kola-kowska T, Mandelbrote B M, Marshall J, Murray M AF, Wiles D H. The effects of phenothiazines on endocrine function: II. Effects in mean and post-menopausal women. Br J Psychiatr 1974; 124: 420–430
   PubMed Web of Science ®Google Scholar
• Buckman M T, Peake G T. Estrogen potentiation of phenothiazine-induced prolactin secretion in man. J Clin Endocrinol Metab 1973; 37: 977–980
   Google Scholar
• De Rivera J L, Lai S, Ettigi P, Hontela S, Muller H F, Friesen H G. Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups. Clin Endocrinol 1976; 5: 273–282
   PubMed Web of Science ®Google Scholar
• Fang V S, Refetoff S, Rosenfield R L. Hypogonadism induced by a transplantable prolactin-producing tumor in male rats: hormonal and morphological studies. Endocrinology 1974; 95: 991–998
   PubMed Web of Science ®Google Scholar
• Fossati P, Strauch G, Toumiaire Y. Etude de ľ activité de la bromocriptine dans les états ď hyperprolactinémie-Résultats ď un essai coopératif chez 135 patients. Press Méd 1976; 5: 1687–1691
   Google Scholar
• Friesen H, Guyda H, Hwang P, Tyson J E, Barbeau A. Functional evaluation of prolactin secretion: a guide to therapy. J Clin Invest 1972; 51: 706–709
   PubMed Web of Science ®Google Scholar
• Gala R R, Boss R S. Serum prolactin levels of rats under continuous estrogen stimulation and 2 Br-α-ergocryptine (CB-154) injection. Proc Soc Exp Biol Med 1975; 149: 330–332
   Google Scholar
• Gold E M, Di Raimondo V C, Kent J R, Firsham P H. Comparative effects of certain nonnarcotic central system analgesic and muscle relaxants on the pituitary-adrenocortical system. Ann New York Acad Sci 1960; 86: 178–183
   Google Scholar
• Hafiez A A, Lloyd C W, Bartke A. The role of prolactin in the regulation of testis function: the effects of prolactin and luteinizing hormones on the plasma levels of testosterone and andro-stenedione in hypophysectomized rats. J Endocrinol 1972; 52: 327–332
   PubMed Web of Science ®Google Scholar
• Harper M E, Peeling W B, Cowley T, Brownsey B G, Phillips M EA, Groom G, Fahmy D R, Griffiths K. Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma before and during estrogen therapy. Acta Endocr 1976; 81: 409–426
   PubMedGoogle Scholar
• McNatty K P, Sawers R S, McNeilly A S. A possible role for prolactin in control of steroid secretion by the human graafian follicle. Nature 1974; 250: 653–655
   PubMed Web of Science ®Google Scholar
• Magnni G, Ebiner J R, Burckhardt P, Felber J P. Study on the relationship between plasma prolactin and androgen metabolism in man. J Clin Endocrinol Metab 1976; 43: 944–947
   Google Scholar
• Magrini G, Felber J P. Radioimmunoassay of steroid hormone: Principles and Methods. Clinical Biochemistry, H Ch Curtius, M Roth. W. de Gruyter, Berlin 1974; 783–790
   Google Scholar
• Magrini G, Iselin H U, Ebiner J R, Felber J P. New aspects of androgens, prolactin and ACTH interactions in men. Arch Androl 1979; 2: 141–155
   PubMed Web of Science ®Google Scholar
• Magrini G, Méan F, Martin du Pan R, Baumann P, Felber J P. Testicular function during chronic neuroleptic therapy. Neuroendo-crinology: Biological and Clinical Aspects, A Polleri, R M McLeod. Academic Press, London, New York 1979; 351–357
   Google Scholar
• Magrini G, Rousselle J, Horowski R, Gasperi M, Felber J P. Testicular and adrenal steroid profiles during PRL suppression by lisuride in men. J Andrology 1980, in press
   Google Scholar
• Mahoudeau J A, Bardin C W, Lipsett M B. The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5a-androstanediols. J Clin Invest 1971; 50: 1338–1344
   PubMed Web of Science ®Google Scholar
• Meltzer H Y, Fang V S. The effect of neuroleptics on serum prolactin in schizophrenic patients. Arch Gen Psychiatry 1976; 33: 279–286
   PubMed Web of Science ®Google Scholar
• Rubin R T, Poland R E, Tower B B. Prolactin-related testosterone secretion in normal adult men. J Clin Endocrinol Metab 1976; 42: 112–116
   PubMed Web of Science ®Google Scholar
• Sloane R B, Saffran M, Cleghorn R A. Steroid response to ACTH and the effect of ataractic drugs. Psychoendocrinology, M Reiss. Grune and Stratton, New York 1958; 198–202
   Google Scholar
• Strott C A, Yoshimi T, Lipsett M G. Plasma progesterone and 17-hydroxyprogesterone in normal men and children with congenital adrenal hyperplasia. J Clin Invest 1969; 48: 930–939
   PubMed Web of Science ®Google Scholar
• Suominen J JO, Nikkanen V, Multamaki S, Hyyppa M. Prolactin in azoospermic men and its relation to testicular morphology, serum testosterone and gonadotrophin levels. Andrologia 1979; 11: 15–19
   Google Scholar
• Thorner M O, McNeilly A S, Hagan C, Besser G M. long-term treatment of galactorrhea and hypogonadism with bromocriptine. Br Med J 1974; 2: 419–422
   PubMed Web of Science ®Google Scholar
• Tolis G, Pinter E, Friesen H G. The acute effect of 2-bromo-α-ergocriptine (CB 154) on anterior pituitary hormones and free fatty acids in man. Int J Clin Pharmacol 1975; 12: 281–283
   Google Scholar